January 07, 2021

Sage Therapeutics

Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference

January 07, 2021

Constellation Pharmaceuticals

Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer

January 07, 2021

Kala Pharmaceuticals

Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline

January 07, 2021

Nurix

Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

January 05, 2021

Bristol Myers Squibb and bluebird bio Present Data Highlighting Anti-BCMA CAR T Cell Therapy, Ide-cel, in Relapsed and Refractory Multiple Myeloma at ASH 2020

Load More

Sign up for weekly portfolio news.